Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
Research output: Contribution to journal › Article
Standard
Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum. / McCallum, F. J.; Persson, Kristina; Mugyenyi, C. K.; Fowkes, F. J. I.; Simpson, J. A.; Richards, J. S.; Williams, T. N.; Marsh, K.; Beeson, J. G.
In: PLoS ONE, Vol. 3, No. 10, e3571, 2008.Research output: Contribution to journal › Article
Harvard
APA
CBE
MLA
Vancouver
Author
RIS
TY - JOUR
T1 - Acquisition of Growth-Inhibitory Antibodies against Blood-Stage Plasmodium falciparum
AU - McCallum, F. J.
AU - Persson, Kristina
AU - Mugyenyi, C. K.
AU - Fowkes, F. J. I.
AU - Simpson, J. A.
AU - Richards, J. S.
AU - Williams, T. N.
AU - Marsh, K.
AU - Beeson, J. G.
N1 - 10
PY - 2008
Y1 - 2008
N2 - Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood. Methods: We tested dialysed serum and purified immunoglobulins from Kenyan children and adults for inhibition of P. falciparum blood-stage growth in vitro using different parasite lines. Serum antibodies were measured by ELISA to blood-stage parasite antigens, extracted from P. falciparum schizonts, and to recombinant merozoite surface protein 1 (42 kDa C-terminal fragment, MSP1-42). Results: Antibodies to blood-stage antigens present in schizont protein extract and to recombinant MSP1-42 significantly increased with age and were highly correlated. In contrast, growth-inhibitory activity was not strongly associated with age and tended to decline marginally with increasing age and exposure, with young children demonstrating the highest inhibitory activity. Comparison of growth-inhibitory activity among samples collected from the same population at different time points suggested that malaria transmission intensity influenced the level of growth-inhibitory antibodies. Antibodies to recombinant MSP1-42 were not associated with growth inhibition and high immunoglobulin G levels were poorly predictive of inhibitory activity. The level of inhibitory activity against different isolates varied. Conclusions: Children can acquire growth-inhibitory antibodies at a young age, but once they are acquired they do not appear to be boosted by on-going exposure. Inhibitory antibodies may play a role in protection from early childhood malaria.
AB - Background: Antibodies that inhibit the growth of blood-stage Plasmodium falciparum may play an important role in acquired and vaccine-induced immunity in humans. However, the acquisition and activity of these antibodies is not well understood. Methods: We tested dialysed serum and purified immunoglobulins from Kenyan children and adults for inhibition of P. falciparum blood-stage growth in vitro using different parasite lines. Serum antibodies were measured by ELISA to blood-stage parasite antigens, extracted from P. falciparum schizonts, and to recombinant merozoite surface protein 1 (42 kDa C-terminal fragment, MSP1-42). Results: Antibodies to blood-stage antigens present in schizont protein extract and to recombinant MSP1-42 significantly increased with age and were highly correlated. In contrast, growth-inhibitory activity was not strongly associated with age and tended to decline marginally with increasing age and exposure, with young children demonstrating the highest inhibitory activity. Comparison of growth-inhibitory activity among samples collected from the same population at different time points suggested that malaria transmission intensity influenced the level of growth-inhibitory antibodies. Antibodies to recombinant MSP1-42 were not associated with growth inhibition and high immunoglobulin G levels were poorly predictive of inhibitory activity. The level of inhibitory activity against different isolates varied. Conclusions: Children can acquire growth-inhibitory antibodies at a young age, but once they are acquired they do not appear to be boosted by on-going exposure. Inhibitory antibodies may play a role in protection from early childhood malaria.
KW - recombinant merozoite surface protein 1
KW - parasite antibody
KW - merozoite surface protein 1
KW - immunoglobulin G
KW - unclassified drug
KW - protozoon antibody
U2 - 10.1371/journal.pone.0003571
DO - 10.1371/journal.pone.0003571
M3 - Article
VL - 3
JO - PLoS ONE
JF - PLoS ONE
SN - 1932-6203
IS - 10
M1 - e3571
ER -